 "Marksans Pharma soars as UK MHRA finds no critical observations at Goa unit")
Marksan Pharma surged 20% to Rs 49 on the BSE in intra-day trade after the company said UK health regulator has completed the inspection of Goa unit without any critical observations.
“The Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14, 2017 to February 17, 2017,” Marksans Pharma said in a exchanges filing.
The same has been completed without any critical observations, it added.
The company said it is awaiting further instructions from the agency in this regard.
At 12:43 pm; the stock was up 19.5% at Rs 48.50 on back of over 10-fold jump in trading volumes. A combined 37.42 million shares representing 9% of total equity of Marksans Pharma changed hands on the counter on the BSE and NSE.
“The Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14, 2017 to February 17, 2017,” Marksans Pharma said in a exchanges filing.
The same has been completed without any critical observations, it added.
The company said it is awaiting further instructions from the agency in this regard.
At 12:43 pm; the stock was up 19.5% at Rs 48.50 on back of over 10-fold jump in trading volumes. A combined 37.42 million shares representing 9% of total equity of Marksans Pharma changed hands on the counter on the BSE and NSE.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%